Analyst price target range
Immunome Price Target: $36.31 Average
Direct answer
Immunome's average price target is $36.31.
The verified analyst range runs from $30.00 to $40.00.
The low target implies +27.9%, the high target implies +70.5%, and the range spans 42.6% of the current price.
Forecast evidence checked September 17, 2026.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $23.46
- Average price target
- $36.31
- High price target
- $40.00
- Low price target
- $30.00
- Low target gap
- +27.9%
- Target upside
- +54.8%
- High target gap
- +70.5%
- Target range width
- 42.6%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is Immunome's average price target?
Immunome's verified average price target is $36.31. The target range is $30.00 to $40.00.
How far are Immunome's low and high targets from the recorded price?
The low target implies +27.9%, while the high target implies +70.5%.
How many analysts are included in Immunome's consensus?
The verified consensus includes 13 analysts.
How is Immunome's target upside or downside calculated?
The average target of $36.31 is divided by the recorded price of $23.46, then one is subtracted to produce +54.8%. This does not guarantee a future return.
When was Immunome's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.